Latest Regulatory Scrutiny News

The Takeovers Panel has issued interim orders extending the deadline for Mayne Pharma's takeover scheme with Cosette Pharmaceuticals, preventing termination without consent and maintaining the status quo.

Solvar Limited reported solid FY25 results with profit growth, a significant dividend hike, and a positive outlook for FY26 driven by loan originations and commercial lending expansion.

The Foreign Investment Review Board has extended its deadline for approving Mayne Pharma's acquisition by Cosette Pharmaceuticals, maintaining the current transaction timetable for now.

The ACCC has given informal clearance for the merger between Southern Cross Media Group and Seven West Media, marking a key regulatory milestone. The deal still awaits shareholder and ACMA approvals before completion.

Sagalio Energy Limited’s shares have been suspended from ASX trading due to compliance concerns, leaving investors in the dark about the company’s next steps.

Mt Malcolm Mines NL has suspended trading of its M2MOA securities pending regulatory compliance, signaling a cautious pause for investors.

ANZ Group Holdings reported a 10% decline in cash profit for FY2025 despite an 8% rise in operating income, maintaining its dividend amid significant restructuring and regulatory costs.

Block, Inc. reported a modest 2% revenue increase in Q3 2025 driven by growth in its Cash App and Square segments, alongside a $461.5 million net income. The company issued $2.2 billion in senior notes and repurchased $1.5 billion in stock, while navigating ongoing regulatory scrutiny and legal challenges.

Macquarie Group Limited reported a 3% increase in half-year profit to $1.655 billion, driven by growth across its asset management, banking, commodities, and capital markets divisions. The group maintains robust capital and liquidity positions despite margin pressures and regulatory challenges.

James Hardie Industries faces intense scrutiny from the ASX after its share price dropped sharply and trading volumes spiked, prompting urgent questions about undisclosed information.

Bentley Capital Limited is poised to lift its trading suspension on 6 November 2025 following a key announcement addressing legal costs and regulatory queries.

Bentley Capital Limited has voluntarily suspended trading of its shares on the ASX pending a market announcement addressing a recent price and volume query. The suspension is expected to last until early November, signaling heightened regulatory scrutiny.